EditorialRadiotherapy for Benign Disease: Current Evidence, Benefits and Risks
Section snippets
Acknowledgements
We would like to thank Mrs Gillian Dollamore for co-ordinating the project, members of the Faculty Board of the Royal College of Radiologists Clinical Oncology Faculty for reviewing the manuscript and for helpful suggestions and the production team of the Royal College of Radiologists for production of the document to which this editorial refers.
References (17)
- et al.
Responses of normal cells to ionizing radiation
Semin Radiat Oncol
(2007) - et al.
Radiation fibrosis - current clinical and therapeutic perspectives
Clin Oncol
(2012) - et al.
Pathogenetic mechanisms in radiation fibrosis
Radiother Oncol
(2010) - et al.
Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial
Int J Radiat Oncol Biol Phys
(2004) - et al.
Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship
Int J Radiat Oncol Biol Phys
(2013) Seegenschmiedt MH for the German Working Group of Radiotherapy of Benign Diseases. Consensus guidelines for radiation therapy of benign diseases: a multicentre approach in Germany
Int J Radiat Oncol Biol Phys
(2002)- et al.
Radiotherapy of non-malignant disorders: where do we stand?
Radiother Oncol
(2007)
There are more references available in the full text version of this article.
Cited by (15)
Is There Still a Role for Radiation Therapy in the Management of Benign Disease?
2023, Clinical OncologyA survey of Belgian practice for non-malignant diseases
2020, Cancer/RadiotherapieBariatric Radioembolization: A Pilot Study on Technical Feasibility and Safety in a Porcine Model
2016, Journal of Vascular and Interventional RadiologyAlternative treatment options for periocular basal cell carcinoma: a narrative review
2022, Frontiers of Oral and Maxillofacial Medicine
Copyright © 2015 Published by Elsevier Ltd.